about
Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1Recent developments regarding periostin in bronchial asthmaAugmentation of signal transducer and activation of transcription (STAT)6 and STAT3 expression in stimulated B and T cellsThe squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapiesCharacterization of the interaction between interleukin-13 and interleukin-13 receptorsIdentification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary diseaseAnalysis of novel disease-related genes in bronchial asthma.Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells.Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.Signal transduction of IL-13 and its role in the pathogenesis of bronchial asthma.IL-13: a promising therapeutic target for bronchial asthma.Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis.Cellular and molecular mechanisms of TSLP function in human allergic disorders--TSLP programs the "Th2 code" in dendritic cells.Identification of IL-17-producing FOXP3+ regulatory T cells in humans.Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family.Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis.Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts.Periostin in allergic inflammation.Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1α/IL-6 loop.Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell linesSquamous cell carcinoma antigen 1 is an inhibitor of parasite-derived cysteine proteases.Involvement of IL-32 in activation-induced cell death in T cells.Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells.Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma.Periostin promotes chronic allergic inflammation in response to Th2 cytokines.Expression of the extracellular region of the human interleukin-4 receptor alpha chain and interleukin-13 receptor alpha1 chain by a silkworm-baculovirus system.Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme.Characterization of novel squamous cell carcinoma antigen-related molecules in mice.Involvement of cysteine protease inhibitors in the defense mechanism against parasites.The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey.Localization of human interleukin 13 receptor in non-haematopoietic cells.Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-β signaling.Constitutive overexpression of periostin delays wound healing in mouse skin.Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts.
P50
Q24318950-2C0D1CA8-09B2-4336-A084-A8CC98E9319EQ26783543-35C1B7B6-6A15-40D7-98B1-529DB24E6FABQ28141237-EF5F8AE8-30DC-4D85-B032-08D5C203FD8FQ28186148-F370B8C1-CBA5-49CF-98C7-587EC8DE55ACQ28210238-B961D276-13E1-4C8F-A278-084F3AF87870Q28248430-FF4E0907-3A29-4C81-AF4C-7F1F424CA429Q28277144-F454C5C9-AA79-4AD5-B2B5-258BBDA630DAQ33185122-82BB6082-DDC7-4809-973D-596F97778E79Q33805974-87CEA0CC-9A4E-4AAA-9DAB-D23E88623AB3Q34629965-B445D751-10C3-4193-89C7-7B634AC676D8Q35005706-EDF15942-E43A-4394-8511-FB9BC3AB5028Q35751209-4A9C7C5D-1C16-4D27-B564-030B627DAFE2Q36570006-8E2F8234-E0A9-4DF6-9112-9250CF9543D5Q36691823-55B92553-B79F-4F21-BAA5-29E7B70C9D09Q36865256-757D2F1D-4ADC-49DA-8604-D2E8207AB808Q37122868-8D7CD6C6-C0B7-4695-8CE4-E4DFFC0F7365Q37178986-8CD7C6CF-1CF8-4BF2-B483-7511AB6676B3Q37266974-D8415C12-4268-4C16-8CF0-DD99F858EB07Q37377469-9CD8184E-35BA-4EB0-A4DB-DC3DB765A30DQ37655419-05731C38-5F10-4734-84FA-8B8F9BCA6B54Q38198913-DC5E771F-5B2D-48AF-8712-47015282E933Q39042054-EB636A9F-FEF1-4662-8964-14E140C76A43Q39973753-08614BA6-4F06-4832-B82E-8219D1C04741Q40091882-9E4D2ECA-17E6-4D6C-B365-23122D855191Q40330495-AC41BE2C-881C-4060-8BB4-134E44DE55BEQ40420970-0ED9D699-010C-4FB3-BA62-82A320135E86Q40725450-434800A7-D9B2-4442-9B69-6D81DED2F12DQ41926592-94A64216-D51D-4AFC-8237-A164CF96AB21Q42029311-DD3E7260-63DC-4EB6-B6FD-7241C6286579Q43095588-2B882E66-69D3-40F5-8E60-8FBA8117F9E9Q45074720-ED375AF2-651E-4144-B42E-3D4052E6D28AQ45123877-0741D845-D0D3-4BE2-ACED-175D3BE40E51Q46450511-6C18539C-CAEA-45D6-9410-3F60B7EA3557Q46765346-2E565C6D-96CC-4597-97B6-2A4D6E5F10AAQ47638497-00A0612B-39AA-443C-8F21-8AA41466A2C8Q49107513-6534CBD5-928F-446C-BABD-BC38DCDC4443Q50056736-E38B3664-628C-4966-9F1C-CAED718A33BEQ50123422-A34DB234-30B0-48CF-9292-6215328ED721Q52669715-BDDB1CAC-622F-4272-9E80-6D27823D9BDFQ53173701-82D590D7-C567-4108-9951-2023A2210EBD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kazuhiko Arima
@ast
Kazuhiko Arima
@en
Kazuhiko Arima
@es
Kazuhiko Arima
@nl
Kazuhiko Arima
@sl
type
label
Kazuhiko Arima
@ast
Kazuhiko Arima
@en
Kazuhiko Arima
@es
Kazuhiko Arima
@nl
Kazuhiko Arima
@sl
altLabel
Kazu Arima
@en
prefLabel
Kazuhiko Arima
@ast
Kazuhiko Arima
@en
Kazuhiko Arima
@es
Kazuhiko Arima
@nl
Kazuhiko Arima
@sl
P1053
I-8962-2014
P106
P108
P1153
7101813702
P21
P31
P3829
P496
0000-0002-0607-8787